Skip to main content Accessibility help
×
Hostname: page-component-77c89778f8-vpsfw Total loading time: 0 Render date: 2024-07-20T08:17:33.207Z Has data issue: false hasContentIssue false

22 - Antiepileptic medication effects

from Part II - Learning problems

Published online by Cambridge University Press:  26 October 2009

Get access

Summary

In 1948, William Lennox observed: “Many physicians, attempting to extinguish seizures, only succeed in drowning the intellectual process of the patient.” The goal of therapy is to stop the seizures without stopping the patient's functioning. With antiepileptic medications, the question concerns not the best drug for the seizure type but rather the best drug for the child.

Anticonvulsants

The goal of modern drug treatment for epilepsy should be the cessation of seizures but also the prevention of cognitive and behavior dysfunctions (Billard, 1999). All anticonvulsant drugs impair cognitive functions to some degree, although some do so more than others. The longer a drug is in use, the longer becomes the list of side effects associated with it. No single drug causes problems in every patient. No drug can be assumed to never cause any cognitive impairment (Bourgeois, 2002). Adverse effects on learning and behavior usually appear by one month after beginning an antiepileptic medication (Henricksen, 1990). The effects of antiepileptic drugs on brain development and cognitive functioning need to be considered when choosing which antiepileptic to use (Alpherts & Aldenkamp, 1990; Blennow et al., 1990; Rugland, 1990; Trimble, 1990).

Adverse effects

Antiepileptic medications at excessive dosages impair both behavior and cognition, even if used alone (Matthews & Harley, 1975; Stores & Piran, 1978; Bourgeois et al., 1983; Reila, 1998). Although drug levels can be checked, the standard therapeutic ranges signify only a level needed and tolerated in many patients; there are exceptions.

Type
Chapter
Information
Childhood Epilepsy
Language, Learning and Behavioural Complications
, pp. 337 - 361
Publisher: Cambridge University Press
Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Addy, D. P. (1987). Cognitive function in children with epilepsy. Dev. Med. Child Neurol. 29: 394–404CrossRefGoogle ScholarPubMed
Ahmed, M., Besag, F., Fowler, M., et al. (1998). Efficacy and safety of topiramate in patients with severe epilepsy and learning disabilities. 3rd European Congress of Epileptology. Epilepsia 39 (suppl 2): 3Google Scholar
Aikia, M., Kalviainen, R. & Riekinen, P. P. J. Sr (1999). The cognitive effects of initial tiagabine monotherapy. Epilepsia 40 (suppl 7): 51Google Scholar
Aikia, M., Kalvianen, R., Sivenius, J., et al. (1992). Cognitive effects of oxycarbamazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res. 1: 199–203CrossRefGoogle Scholar
Aldenkamp, A. P. (1997). Effect of seizures and epileptiform discharges on cognitive function. Epilepsia 38 (suppl 1): 52–5CrossRefGoogle ScholarPubMed
Aldenkamp, A. P. (2001). Effects of antiepileptic drugs on cognition. In Epilepsia and Learning Disabilities, ed. G. F. Ayala, M. Elia, C. M. Cornaggia & M. M. Trimble. Epilepsia 42: 46–9CrossRef
Aldenkamp, A. P., Alpherts, W. C. J., Blennow, G., et al. (1993). Withdrawal of antiepileptic medication in children-effects on cognitive function: the Multicenter Holmfrid study. Neurology 43: 41–50CrossRefGoogle ScholarPubMed
Aldenkamp, A. P., Alpherts, W. C. J., Dekker, M. J. A.et al. (1990). Neuropsychological aspects of learning disabilities in epilepsy. Epilepsia 31 (suppl 4): 9–20CrossRefGoogle ScholarPubMed
Aldenkamp, A. P., Alpherts, W. C. J., Moerland, M. C. P., et al. (1987). Controlled release carbamazepine: cognitive side-effects in patients with epilepsy. Epilepsia 28: 507–14CrossRefGoogle ScholarPubMed
Aldenkamp, A. P., Baker, G., Mulder, O. G., et al. (2000). A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 41: 1167–78CrossRefGoogle ScholarPubMed
Alpherts, W. C. J. & Aldenkamp, P. A. (1990). Computerized neuropsychological assessment of cognitive functioning in children with epilepsy. Epilepsia 31 (suppl 4): 35–40CrossRefGoogle ScholarPubMed
Aman, M. G., Werry, J. S., Paxton, J. W. & Turbott, S. H. (1987). Effects of sodium valproate on psychomotor performance in children as a function of drug concentration, fluctuations in concentration and diagnosis. Epilepsia 28: 115–24CrossRefGoogle ScholarPubMed
Aman, M. G., Werry, J. S., Paxton, J. W., et al. (1990). Effects of carbamazepine on psychomotor performance in children as a function of dose, concentration, seizure type and time of mediation. Epilepsia 31: 51–60CrossRefGoogle Scholar
Andrewes, D. G., Bullen, J. G., Tomlinson, L., et al. (1986). A comparative study of the cognitive effects of phenytoin and carbamazepine in new referrals with epilepsy. Epilepsia 27: 128–34CrossRefGoogle ScholarPubMed
Baeta, E. M., Santana, I. M., Castro, G., et al. (2000). Topiramate therapy in patients with intractable epilepsy: cognitive effects. Epilepsia 41 (suppl 7): 234Google Scholar
Bailet, L. L. & Turk, W. R. (1991). The influence of antiepileptic therapy on academic achievement in childhood-onset epilepsy. Epilepsia 32 (suppl 3): 73Google Scholar
Bailet, L. L. & Turk, W. R. (2000). The impact of childhood epilepsy on neurocognitive and behavior performance: a prospective longitudinal study. Epilepsia 41: 426–31CrossRefGoogle ScholarPubMed
Banks, G. K. & Beran, R. G. (1991). Neuropsychological assessment in Lamotrigine treated epileptic patients. Clin. Exp. Neurol. 28: 230–37Google ScholarPubMed
Barlow, C. F. (1978). Risk factors of infancy and childhood: interrelationship of seizure disorders and mental retardation. In Mental Retardation and Related Disorders, pp. 68–75. Philadelphia: F. A. Davis
Bennett-Levy, J. & Stores, G. (1984). The nature of cognitive dysfunction in schoolchildren with epilepsy. Acta Neurol. Scand. 69 (suppl 99): 79–82CrossRefGoogle Scholar
Berent, S., Sackellares, J. C., Giordani, B., et al. (1987). Zonisamide (CI-912) and cognition: results from preliminary study. Epilepsia 28: 61–7CrossRefGoogle ScholarPubMed
Besag, F. C. (2001). Treatment of state-dependent learning disabilities. In Epilepsia and Learning Disabilities, ed. G. F. Ayala, M. Elia, C. M. Cornaggia & M. M. Trimble. Epilepsia 42: 46–9CrossRef
Billard, C. (1999). Anti-epileptic drugs and cognitive function. In Childhood Epilepsies and Brain Development, ed. A. Nehlig, J. Motte, S. L. Moshe & P. Plouin, pp. 279–88. London: John Libbey & Co
Blank, J. R. & Anderson, R. J. (1983). The effects of anticonvulsant drugs on rehabilitation and employment of epileptics. J. Rehabil. 49: 61–3Google ScholarPubMed
Blennow, G., Heijbel, J., Sandstedt, P., et al. (1990). Discontinuation of antiepileptic drugs in children who have outgrown epilepsy: effects on cognitive function. Epilepsia 31 (suppl 4): 50–53CrossRefGoogle ScholarPubMed
Bourgeois, B. F. D. (2002). Differential cognitive effects of antiepileptic drugs. J. Child Neurol. 17: 2828–33CrossRefGoogle ScholarPubMed
Bourgeois, B. F. D., Presky, A. I., Palkes, H. S., et al. (1983). Intelligence in epilepsy: a prospective study in children. Ann. Neurol. 14: 438–44CrossRefGoogle ScholarPubMed
Browne, T. R. (1980). Drug therapy: valproic acid. N. Engl. J. Med. 302: 661–4Google Scholar
Browne, T. R., Dreifuss, F. E., Dyken, P. R., et al. (1975). Ethosuximide (Zarontin) in the treatment of absence (petit mal) seizures. Neurology 25: 515–24CrossRefGoogle ScholarPubMed
Browne, T. R., Penry, S. K., Porter, R. & Dreifuss, F. (1974). Responsiveness before, during and after spike-wave paroxysms. Neurology 24: 59–66CrossRefGoogle ScholarPubMed
Burton, L. A. & Harden, C. (1996). Effect of topiramate on attention. Epilepsy Res. 27: 29–32CrossRefGoogle Scholar
Butlin, A. I., Danta, G. & Cook, M. L. (1984). Anticonvulsant effects on the memory performance of epileptics. Clin. Exp. Neurol. 20: 27–35Google ScholarPubMed
Camfield, P. R., Camfield, C. S., Gates, R., et al. (1986). Changes in serum carbamazepine or carbamazepine-10-11-epoxide levels do not alter reaction time in children with stable epilepsy. Ann. Neurol. 20: 428Google Scholar
Camfield, C. S., Chaplin, S., Doyle, A. B., et al. (1977). Side effects of phenobarbital in toddlers: behavior and cognitive aspects. Pediatrics 95: 361–5CrossRefGoogle Scholar
Camfield, C. S., Chaplin, S. & Doyle, A. B. (1979). Side effect of phenobarbital in toddlers: behavior and cognitive aspects. J. Pediatr. 95: 361–5CrossRefGoogle Scholar
Caner, A. R., Comargo, C. H. P., Cukiert, A., et al. (1991). Cognitive effects of vigabatrin. 19th International Epilepsy Congress. Epilepsia 32 (suppl 1): 102–3Google Scholar
Chen, Y., Chi Chow, J. & Lee, I. (2001). Comparison of the cognitive effect of antiepileptic drugs in seizure-free children with epilepsy before and after drug withdrawal. Epilepsy Res. 44: 65–70CrossRefGoogle ScholarPubMed
Coenen, A. M. I., Groothasen, J., Luijtellar, E. L. J. M., et al. (1991). Effects of discontinuation of carbamazepine and valproate on cognitive functioning in children. 19th International Epilepsy Congress. Epilepsia 32 (suppl 1): 56–7Google Scholar
Concepcion, S., Werz, M. A., Avery, J., et al. (2000). Tiagabine induced spike-wave stupor in patients with partial epilepsy. Epilepsia 41 (suppl 7): 104Google Scholar
Corbett, J. A., Trimble, M. R. & Nichol, T. C. (1985). Behavioral and cognitive impairments in children with epilepsy: the long-term effects of anticonvulsant therapy. J. Am. Acad. Child Psychiatry 24: 17–23CrossRefGoogle ScholarPubMed
Cornaggia, C. M. & Gobbi, G. (2001). Learning disability in epilepsy: definitions and classification. In Epilepsia and Learning Disabilities, ed. G. F. Ayala, M. Elia, C. M. Cornaggia & M. M. Trimble. Epilepsia 42: 2–5CrossRef
Coulter, D. L. III, Wu, H. & Allen, R. J. (1980). Valproic acid therapy in childhood epilepsy. JAMA 44: 788Google Scholar
Cull, C. A. (1988). Cognitive function and behavior in children. In Epilepsy, Behavior and Cognitive Function, ed. M. R. Trimble & E. H. Reynolds, pp. 97–111. Chichester, UK: John Wiley & Sons
Curran, H. V., Java, R. & Luder, M. H. (1991). Cognitive and psychomotor effects of oxcarbamazepine. 19th International Epilepsy Congress, Rio De Janeiro, Brazil. Epilepsia 32 (suppl 1): 56Google Scholar
Dikmen, S. (1980). Neuropsychological aspects of epilepsy. In A Multidisciplinary Handbook of Epilepsy, ed. B. P. Hermann, pp. 236–73. Springfield, IL: Charles C. Thomas
Dodrill, C. B. (1975). Diphenylhydantoin serum levels, toxicity and neuropsychological performance in patients with epilepsy. Epilepsia 16: 593–600CrossRefGoogle ScholarPubMed
Dodrill, C. B. (1976). Psychology. In Textbook of Epilepsy, ed. J. Laidlaw & A. Reichens, Vol. II, pp. 282–91, New York: Churchill Livingstone
Dodrill, C. B. (1980). Neuropsychological evaluation in epilepsy. In Epilepsy: A Window to Brain Mechanisms, ed. J. S. Lockard & A. A. Ward, Jr, pp. 231–41. New York: Raven Press
Dodrill, C. B. (1998). The effects of seizures and various AEDs on cognition. Presented at the American Epilepsy Society Conference, San Diego, CA, 1998
Dodson, W. E. (1988). Aspects of antiepileptic treatment in children. Epilepsia 29 (suppl 3): 10–14CrossRefGoogle ScholarPubMed
Doherty, K. T. & Gates, J. R. (1999). Use of topiramate in the cognitively impaired. Epilepsia 40 (suppl 7): 62Google Scholar
Dreifuss, F. E. (1983). Pediatric Epileptology. Boston, MA: John Wright PSG Inc
Duncan, J. S., Shorvon, S. D. & Trimble, M. R. (1990). Effects of removal of phenytoin, carbamazepine and valproate on cognitive function. Epilepsia 31: 584–91CrossRefGoogle ScholarPubMed
Farnham, S. J., Reisse, G. L., Gustafson, M., et al. (1999). Effect of topiramate on cognitive test performance. Epilepsia 40 (suppl 7): 52Google Scholar
Farrell, K., Jan, J. E., Julian, J. V., et al. (1984). Clobazam in children with intractable seizures. Epilepsia 25: 657Google Scholar
Farwell, J. R., Lee, Y. J., Hirtz, D. G., et al. (1990). Phenobarbital for febrile seizures – effects on intelligence and on seizure recurrence. N. Engl. J. Med. 322: 364–9CrossRefGoogle ScholarPubMed
Fenelon, B., Holland, J. T. & Johnson, C. (1972). Spatial organization of the EEG in children with reading disabilities: a study using nitrazepam. Cortex 8: 444–64CrossRefGoogle ScholarPubMed
Forsythe, I.Butler, R., Berg, I. & McGuire, R. (1991). Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev. Med. Child Neurol. 33: 524–34CrossRefGoogle ScholarPubMed
Gadow, K. D. (1982). School involvement in the treatment of seizure disorders. Epilepsia 23: 215–24CrossRefGoogle ScholarPubMed
Gallassi, R., Morreale, A., Lorusso, S., et al. (1988). Carbamazepine and phenytoin, comparison of cognitive effects in epileptic patients during monotherapy and withdrawal. Arch. Neurol. 45: 892–4CrossRefGoogle ScholarPubMed
Gallassi, R., Morreale, A., Lorusso, S., et al. (1990). Cognitive effects of valproate. Epilepsy Res. 5: 160–64CrossRef
Gendron, C. N., Garnett, W. R., Culbert, J., et al. (1991). The association between valproate serum concentrations and cognitive function. Epilepsia 32 (suppl 3): 49Google Scholar
Gillham, R. A., Blacklaw, J., McKel, P. J., et al. (1993). Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy. J. Neurol. Neurosurg. Psychiatry 56: 1271–5CrossRefGoogle ScholarPubMed
Giordani, B., Berent, S., Sackellares, J. C., et al. (1985). Intelligence test performance of patients with partial and generalized seizures. Epilepsia 26: 37–42CrossRefGoogle ScholarPubMed
Giordani, B., Sackallares, J. C., Miller, S., et al. (1983). Improvements in neuropsychological performance in patients with refractory seizures after intensive diagnostic and therapeutic intervention. Neurology 33: 489–93CrossRefGoogle Scholar
Glaser, G. H. (1972). Diphenylhydantoin toxicity. In Antiepileptic Drugs, ed. D. M. Woodbury, J. K. Penry & R. P. Schmidt, pp. 219–26. New York: Raven Press
Goldberg, J. F. & Burdick, K. E. (2001). Cognitive side effects of anticonvulsants. J. Clin. Psychiatry 62 (suppl 14): 10–15Google ScholarPubMed
Green, J. B., Walcoff, M. & Lucke, J. F. (1982). Phenytoin prolongs far-field somatosensory and auditory evoked potential interpeak latencies. Neurology 32: 58–88CrossRefGoogle ScholarPubMed
Guey, J., Charles, C., Coquery, C., et al. (1967). Study of psychological defects of ethosuximide (Zarontin) on 25 children suffering from petit mal epilepsy. Epilepsia 8: 129–41CrossRefGoogle Scholar
Gutierrez, A., Dreifuss, F. E., Santilli, N., et al. (1984). Psychiatric symptoms associated with progabide. Epilepsia 25: 657Google Scholar
Hara, H. & Fukuyama, Y. (1989). Sustained attention during the interictal period of mentally normal children with epilepsy or febrile convulsions and the influence of anticonvulsants and seizures on attention. Jpn. J. Psychiatry Neurol. 43: 411–16Google ScholarPubMed
Harding, G. F. A. & Pullen, J. J. (1977). The effect of sodium valproate in the EEG, the photosensitive range, the CNV and reaction time. Electroencephalogr. Clin. Neurophysiol. 43: 465Google Scholar
Harding, G. F. A., Pullen, J. J. & Drasdo, N. (1980). The effect of sodium valproate and other anticonvulsants on performance in children and adolescents. In The Place of Sodium Valproate in the Treatment of Epilepsy, ed. M. J. Parsonage & A. D. S. Caldwell, pp. 61–71. London: Royal Society of Medicine and Academic Press
Hartlage, L. C., Stovall, K. & Kocack, B. (1980). Behavioral correlates of anticonvulsant blood levels. Epilepsia 21: 185Google Scholar
Henricksen, O. (1990). Education and epilepsy: assessment and remediation. Epilepsia 31 (suppl 4): 21–5CrossRefGoogle Scholar
Hosking, G., Spencer, S. & Yuen, A. W. C. (1993). Lamotrigine in children with severe developmental abnormalities in a pediatric population with refractory seizures. Epilepsia 34 (suppl 6): 42Google Scholar
Hutt, S. J., Jackson, P. M., Belsham, A. & Higgers, G. (1968). Perceptual motor behavior in relation to blood phenobarbital level: a preliminary report. Dev. Med. Child Neurol. 10: 626–32CrossRefGoogle ScholarPubMed
Jampaque, I., Dellatolas, G., Dulac, O., et al. (1991). Verbal and visual memory impaired in children with epilepsy. Neuropsychologia 31: 1321–7CrossRefGoogle Scholar
Jeavens, P. M. (1977). Choice of drug therapy in epilepsy. Practitioner 219: 542–56Google Scholar
Jeavens, P. M. & Clark, J. E. (1974). Sodium valproate in the treatment of epilepsy. Br. Med. J. 2: 584–6CrossRefGoogle Scholar
Jus, A. & Jus, K. (1962). Retrograde amnesia in petit mal. Arch. Gen. Psychiatry 6: 163–7CrossRefGoogle ScholarPubMed
Kalviainen, R., Aikia, M., Partanen, J., et al. (1991). Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report. J. Child Neurol. 6: 60–69CrossRefGoogle Scholar
Kelly, K., Stephen, L. J., Sills, G. J., et al. (2002). Topiramate in patients with learning disability and refractory epilepsy. Epilepsia 43: 399–402CrossRefGoogle ScholarPubMed
Kimura, D. (1961). Cerebral dominance and the perception of verbal stimuli. Can. J. Psychol. 15: 166–71CrossRefGoogle Scholar
Koch, S., Titze, K., Zimmermann, R. B., et al. (1999). Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia 40: 1237–43CrossRefGoogle ScholarPubMed
Ladadavas, E., Umilta, C. & Provinciali, L. (1979). Hemisphere dependent cognitive performances in epileptic patients. Epilepsia 20: 493–502CrossRefGoogle Scholar
Laidlaw, J. & Richens, A. (1976). Fits in childhood: education. In A textbook of Epilepsy, ed. J. Laidlaw & A. Richens, pp. 101–2, London: Churchill Livingstone
Lairy, G. C. & Goas, A. L. (1985). Epilepsy in child psychiatry: effects of treatment by dipropylacetic acid. Electroencephalogr. Clin. Neurophysiol. 43: 557–8Google Scholar
Leach, J. P., Girvan, J., Paul, A., et al. (1997). Gabapentin and cognition: a double blind, dose ranging, placebo-controlled study in refractory epilepsy. J. Neurol. Neurosurg. Psychiatry 62: 372–6CrossRefGoogle ScholarPubMed
Levy, R. H., Loiseau, P., Guyot, M., et al. (1984). Stirpental kinetics in epileptic patients: non-linearity and interactions. Epilepsia 25: 675Google Scholar
Lindsay, J., Ounsted, C. & Richards, P. (1980). Long-term outcome I children with temporal lobe seizures IV Genetic factors, febrile convulsions and remission of seizures. Dev. Med. Child Neurol. 22: 429–39CrossRefGoogle ScholarPubMed
Loring, D. W. & Meador, K. J. (2001). Cognitive and behavior effects of epilepsy treatment. Epilepsia. 42 (suppl 8): 24–32CrossRefGoogle Scholar
MacLeod, C. M., Dekaban, A. S. & Hunt, E. (1978). Memory impairment in epileptic patients: selective effects of phenobarbital concentration. Science 202: 1102–4CrossRefGoogle ScholarPubMed
Mandelbaum, D. E., Kugler, S. L., Wenger, E. C., et al. (2001). Clinical experience with levetiracetam and Zonisamide in children with uncontrolled epilepsy. Epilepsia 42 (supp 7): 183Google Scholar
Martin, N. F., Movarrekhi, M. & Gisiger, M. G. (1965). Etude de quelques effets du Tegretol sur une population d'enfants epilepticques. Schweiz Med. Wochenschr. 95: 982–9Google Scholar
Matthews, C. G. & Harley, J. P. (1975). Cognitive and motor-sensory performances in toxic and non-toxic epileptic subjects. Neurology 25: 184–8CrossRefGoogle Scholar
Mayeux, R., Brandt, J., Rosen, J., et al. (1980). Interictal memory and language impairment in temporal lobe epilepsy. Neurology 30: 120–25CrossRefGoogle ScholarPubMed
McCuiston, M., Hartlage, L. C. & Noonan, M. (1983). Stability of correlations between serum phenobarbital levels and neuropsychological test performance. Clin. Neuropsychol. 5: 46Google Scholar
McQuire, A. M., Duncan, J. S. & Trimble, M. S. (1991). Effects of vigabatrin on cognitive function and mood when used as add-on therapy in patients with intractable epilepsy. Epilepsia 33: 128–34CrossRefGoogle Scholar
Meador, K. J. (2001). The effects of antiepileptic drugs on memory. Epilepsia 42 (suppl 7): 219Google Scholar
Meador, K. J. (2002). Cognitive outcomes and predictive factors in epilepsy. Neurology 58 (suppl 5): 21–8CrossRefGoogle ScholarPubMed
Meador, K. J., Kamin, M., Hulihan, J., et al. (2001). Cognitive functions in adults with epilepsy: effect of topiramate and valproate added to carbamazepine. Epilepsia 42 (suppl 2): 75Google Scholar
Meador, K. J., Loring, D. W., Moore, E. E., et al. (1995). Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology 45: 1494–9CrossRefGoogle ScholarPubMed
Meador, K. J., Loring, D. W., Ray, P. G., et al. (1999). Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 40: 1279–85CrossRefGoogle ScholarPubMed
Meador, K. J., Loring, D. W., Ray, P. G., et al. (2000). Effects of carbamazepine and lamotrigine on interrelation of neuropsychological measures. Epilepsia 41 (suppl 7): 235Google Scholar
Meador, K. J., Loring, D. W., Ray, P. G., et al. (2001). Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology 56: 1177–82CrossRefGoogle ScholarPubMed
Mirsky, A. F. (1960). The relationship between paroxysmal EEG activity and performance on a vigilance task in epileptic patients. Am. Psychol. 15: 486Google Scholar
Mirsky, A. F. & Kornetsky, C. (1964). On the dissimilar effects of drugs on the digit symbol substation and continuous performance tests. Psychopharmacologia 5: 161–77CrossRefGoogle Scholar
Mitchell, W. G. & Chavez, J. M. (1987). Carbamazepine versus phenobarbital for partial onset seizures in children. Epilepsia 28: 56–60CrossRefGoogle ScholarPubMed
Mitchell, W. G., Chavez, J. M., Zhon, Y., et al. (1988). Carbamazepine influences reaction time and impulsivity in children with epilepsy. Epilepsia 29: 681Google Scholar
Nolte, R., Wetzel, B., Brugmann, G., et al. (1980). Effects of phenytoin and primidone monotherapy on mental performance in children. In Antiepileptic Therapy: Advances in Drug Monitoring, ed. S. I. Johannesen, P. L. Morselli, C. E. Pippenger, et al., pp. 81–6. New York: Raven Press
O'Dougherty, M., Wright, F. S., Cox, S., et al. (1987). Carbamazepine plasma concentration relationship to cognitive impairment. Arch. Neurol. 44: 853–6, 863–7CrossRefGoogle ScholarPubMed
Ozdirim, E., Renda, Y. & Epur, S. (1978). Effects of phenytoin and phenobarbital upon the behavior of epileptic children. In Advances in Epileptology 1977: Psychology, Pharmacotherapy and New Diagnostic Approaches, ed. H. Meinardi & A. Rowan, pp. 120–23. Amsterdam: Swets & Zeitlinger
Pakalnis, A., Drake, M. E. & Denio, I. (1989). Valproate associated encephalopathy. J. Epilepsy 2: 41–4CrossRefGoogle Scholar
Panel (1998). Questions and answers. Presented at the American Epilepsy Society Conference, San Diego, CA, 1998
Pellock, J. M. (1990). Risk vs. benefits of antiepileptic drug therapy. Int. Pediatr. 5: 177–81Google Scholar
Potolicchio, S. J. Jr, Gut, A. M. & Beaumanoir, A. (1985). Alertness in epileptics: pharmacological and psychometric study. Electroencephalogr. Clin. Neurophysiol. 43: 541Google Scholar
Puente, R. M. (1975). The use of carbamazepine in the treatment of behavioral disorders in children. In Epileptic Seizures – Behavior – Pain, ed. W. Berkmayer, pp. 243–52. Baltimore, MD: University Park Press
Raza, A. M. M. & Fiol, M. (2000). Topirimate can cause non-convulsive status epilepticus. Epilepsia 41 (suppl 7): 220Google Scholar
Reila, A. R. (1998). Special population: cognitive concerns in neorates, the mentally handicapped, and school-aged children. Presented at the American Epilepsy Society Conference, San Diego, CA, 1998
Reinisch, J. M., Sanders, S. A., Mortensen, E. L., et al. (1995). In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 274: 1518–25CrossRefGoogle ScholarPubMed
Reinvang, I., Bjartvei, S., Johannessen, S. I., et al. (1991). Cognitive function and time-of-day variation in serum carbamazepine concentrations in epileptic patients treated with monotherapy. Epilepsia 32: 116–21CrossRefGoogle ScholarPubMed
Rett, A. (1976). The so-called psychoatropic effect of Tegretol in the treatment of convulsions of cerebral oigin in children. In Epileptic Seizures – Behaivor – Pain, ed. W. Birkmayer, pp. 194–204. Bern: Hans Huber
Reynolds, E. H. (1981). Biological factors in psychological disorders associated with epilepsy. In Epilepsy and Psychiatry, ed. E. H. Reynolds & M. R. Trimble, pp. 264–90. New York: Churchill Livingstone
Reynolds, E. H. (1983). Mental effects of antiepileptic medication: a review. Epilepsia 14 (suppl 2): 85–95CrossRefGoogle Scholar
Reynolds, E. H. (1985). Antiepileptic drugs and psychopathology. In The Psychopharmacology of Epilepsy, ed. M. R. Trimble, pp. 49–65. Chichester, UK: John Wiley & Sons
Reynolds, E. H. & Shorvon, S. D. (1981). Monotherapy or polytherapy for epilepsy?Epilepsia 22: 1–10CrossRefGoogle ScholarPubMed
Reynolds, E. H. & Travers, R. D. (1974). Serum anticonvulsant concentrations in epileptic patients with mental symptoms. Br. J. Psychiatry 124: 440–45CrossRefGoogle ScholarPubMed
Riva, D., Milani, N., Pantaleoni, C., et al. (1991). The influence of antiepileptic drugs on cognitive functions in children. 19th International Epilepsy Congress. Epilepsia 32 (suppl 1): 57Google Scholar
Rodin, E. A., Choon So Run, Kitano H., et al. (1976). A comparison of the effectiveness of primidone versus carbamazepine in epileptic out patients. J. Nerv. Ment. Dis. 163: 41–6CrossRefGoogle Scholar
Rodin, E. A., Schmaltz, S. & Twirty, G. (1986). Intellectual functions of patients with childhood-onset epilepsy. Dev. Med. Child Neurol. 28: 25–33CrossRefGoogle ScholarPubMed
Rosen, J. A. (1968). Dilantin dementia. Trans. Am. Neurol. Assoc. 93: 273Google ScholarPubMed
Rugland, A. L. (1990). Neuropsychological assessment of cognitive functioning in children with epilepsy. Epilepsia 31 (suppl 4): 41–4CrossRefGoogle ScholarPubMed
Rutter, M. & Yule, W. (1975). The concept of specific reading retardation. J. Child Psychol. Psychiatry 16: 181–97CrossRefGoogle ScholarPubMed
Sackellares, J. C., Soo, I. I. & Dreifuss, F. E. (1979). Stupor followed by administration of valproic acid in patients receiving other anti-epileptic drugs. Epilepsia 20: 697–703CrossRefGoogle Scholar
Salinsky, M. C., Binder, L. M., Oken, B. S., et al. (2000). Effects of chronic gabapentin and carbamazepine treatment on EEG, alertness and cognition in healthy volunteers. Epilepsia 41 (suppl 7): 151Google Scholar
Sato, S., Penry, J., Dreifuss, F. E., et al. (1977). Clonazepam in the treatment of absence seizures: a double-blind clinical trial. Neurology 27: 371Google Scholar
Schain, R. J. (1983). Carbamazepine and cognitive functioning. In Antiepileptic Drug Therapy, ed. P. L. Morselli, C. E. Pippenger & J. K. Penry, pp. 189–91. New York: Raven Press
Schain, R. J., Ward, J. W. & Guthrie, D. (1977). Carbamazepine as an anticonvulsant in children. Neurology 27: 476–80CrossRefGoogle ScholarPubMed
Shinnar, S. (1991). Treatment decisions in childhood epilepsy. In Epilepsy in Childhood and Its Treatment, ed. W. E. Dodson & J. M. Pellock, pp. 215–22. New York: Demos
Shinnar, S., Vining, P. G., Mellits, E. D., et al. (1985). Discontinuing antiepileptic medication in children with epilepsy after two years without seizures. N. Engl. J. Med. 313: 976–80CrossRefGoogle ScholarPubMed
Shorvon, S. D. & Reynolds, E. H. (1979). Reduction of polypharmacy for epilepsyBr. Med. J. 2: 1023–5CrossRefGoogle ScholarPubMed
Somerfield-Ziskind, E. & Ziskind, E. (1940). Effect of phenobarbital on the mentality of epileptic patients. Arch. Neurol. Psychiatry 43: 70–79CrossRefGoogle Scholar
Sommerbeck, K. W., Theilgaard, A., Rusmussen, K. E., et al. (1977). Valproate sodium: evaluation of so-called psychotropic effects: a controlled study. Epilepsia 18: 159–67CrossRefGoogle ScholarPubMed
Sonnen, A. E. H., Zelvelder, W. H. & Bruens, J. H. (1975). A double blind study of the influence of dipropylacetate on behavior. Acta. Neurol. Scand. Suppl. 60: 43–7CrossRefGoogle Scholar
Stores, G. (1971). Cognitive function in children with epilepsy. Dev. Med. Child Neurol. 13: 390–92CrossRefGoogle ScholarPubMed
Stores, G. (1973). Studies of attention and seizure disorders. Dev. Med. Child Neurol. 15: 376–82CrossRefGoogle ScholarPubMed
Stores, G. (1975). Behavioral effects of antiepileptic drugs. Dev. Med. Child Neurol. 17: 647–58CrossRefGoogle Scholar
Stores, G. (1976). The investigation and management of school children with epilepsy. Publ. Health, Lond. 90: 171–7CrossRefGoogle ScholarPubMed
Stores, G. (1978). School children with epilepsy at risk for learning and behavior problems. Dev. Med. Child Neurol. 20: 502–8CrossRefGoogle Scholar
Stores, G. (1981). Problems of learning and behavior in children with epilepsy. In Epilepsy and Psychiatry, ed. E. H. Reynolds & M. R. Trimble, pp. 33–48. New York: Churchill Livingstone
Stores, G. (1990). Electroencephalographic parameters in assessing the cognitive function of children with epilepsy. Epilepsia 31 (suppl 4): 45–9CrossRefGoogle ScholarPubMed
Stores, G. & Hart, J. (1976). Reading skills of children with generalized or focal epilepsy attending ordinary school. Dev. Med. Child Neurol. 18: 705–16CrossRefGoogle Scholar
Stores, G. & Piran, N. (1978). Dependency of different types in school children with epilepsy. Psychol. Med. 8: 441CrossRefGoogle Scholar
Svoboda W. B. (1979). Anticonvulsant side effects: idiosyncratic reactions. In Learning About Epilepsy, p. 129. Baltimore, MD: University Park Press
Theodore, W. H. & Porter, R. J. (1983). Removal of sedative–hypnotic antiepileptic drugs from the regimens of patients with intractable epilepsy. Ann. Neurol. 13: 320–24CrossRefGoogle ScholarPubMed
Thompson, P. J. (1983). Phenytoin and psychosocial development. In Antiepileptic Drug Therapy in Pediatrics, ed. P. Morselli, C. E. Pippinger & J. K. Penry, pp. 193–200. New York: Raven Press
Thompson, P. J. & Huppert, F. (1980). Problems in the development of measures to test cognitive performance in adult epileptic patients. In Epilepsy and Behaivor'79, ed. B. M. Kulig, H. Meinardi & G. Stores, pp. 37–42. Lisse: Swets & Zeitlinger
Thompson, P. J. & Trimble, M. R. (1981). Sodium valproate and cognitive functioning in normal volunteers. Br. J. Clin. Pharmacol. 12: 819–24CrossRefGoogle ScholarPubMed
Thompson, P. J. & Trimble, M. R. (1982a). Anticonvulsant drugs and cognitive functions. Epilepsia 23: 531–44CrossRefGoogle Scholar
Thompson, P. J. & Trimble, M. R. (1982b). Comparative effects of anticonvulsants on cognitive functioning. Br. J. Clin. Pract. 18 (suppl): 154–6Google Scholar
Thompson, P. J. & Trimble, M. R. (1982c). Sodium valproate and cognitive functioning in normal volunteers. Br. J. Clin. Pharmacol. 12: 819–24CrossRefGoogle Scholar
Thompson, P. J. & Trimble, M. R. (1983). Anticonvulsant serum levels: relationship to impairments of cognitive functioning. J. Neurol. Neurosurg. Psychiatry 46: 227–33CrossRefGoogle ScholarPubMed
Thompson, P. J., Cross, G., Baxendale, S. A., et al. (1999). Changes in intellect and verbal processing in association with topiramate treatment. Epilepsia 40 (suppl 7): 50Google Scholar
Thompson, P. J., Huppert, F. & Trimble, M. R. (1981). Phenytoin and cognitive functions: effect on normal volunteers and implications of epilepsy. Br. J. Clin. Psychol. 20: 155–62CrossRefGoogle ScholarPubMed
Trimble, M. (1980). Antiepileptic drugs and behaivor – discussion notes. In Epilepsy and Behaivor'79, ed. B. M. Kulig, E. Meinardi & G. Stores, pp. 76–9. Lisse: Swets & Zeitlinger
Trimble, M. R. (1982). Anticonvulsant drugs and hysterical seizures. In Pseudoseizures, ed. T. L. Riley & A. Roy, pp. 148–58. Baltimore, MD: Williams & Wilkins
Trimble, M. R. (1983). Anticonvulsant drugs and psychosocial development: phenobarbitone, sodium valproate and benzodiazepines. In Antiepilepsy Drug Therapy in Pediatrics, ed. P. L. Morselli, C. E. Pippenger & J. K. Penry, pp. 201–12. New York: Raven Press
Trimble, M. R. (1987). Anticonvulsant drugs and cognitive function: a review of the literature. Epilepsia 28: 37–45CrossRefGoogle ScholarPubMed
Trimble, M. R. (1988). Anticonvulsant drugs: mood and cognitive functions. In Epilepsy, Behaivor and Cognitive Function, ed. M. R. Trimble & E. H. Reynolds, pp. 135–45. Chichester, UK: John Wiley & Sons
Trimble, M. R. (1990). Antiepileptic drugs, cognitive function and behavior in children: evidence from recent studies. Epilepsia 31 (suppl 4): 30–4CrossRefGoogle ScholarPubMed
Trimble, M. R. & Corbett, J. A. (1980a). Behavioral and cognitive disturbances in epileptic children. Irish Med. J. 73 (suppl): 21–8Google Scholar
Trimble, M. R. & Corbett, J. A. (1980b). Anticonvulsant drugs and cognitive function. In Advances in Epileptology: The Xth Epilepsy International Symposium, ed. J. A. Wada & J. K. Penry, pp. 113–20. New York: Raven Press
Trimble, M. R. & Cull, C. (1990). Children of school age: the influence of antiepileptic drugs on behavior and intellect. Epilepsia 29 (suppl 3): 13–19Google Scholar
Trimble, M. R.Reynolds, E. H. (1976). Anticonvulsant drugs and mental symptoms. Psychol. Med. 6: 169–78CrossRefGoogle ScholarPubMed
Trimble, M. R. & Thompson, P. J. (1981). Memory, anticonvulsant drugs and seizures. Acta Neurol. Scand. 64 (suppl 89): 31–41CrossRefGoogle Scholar
Trimble, M. R. & Thompson, P. J. (1983). Anticonvulsant drugs, cognitive function and behavior. Epilespia 24 (suppl 1): 55–63CrossRefGoogle ScholarPubMed
Trimble, M. R. & Thompson, P. J. (1984a). Anticonvulsant drugs and cognitive function. Epilepsia 25: 642Google Scholar
Trimble, M. R. & Thompson, P. J. (1984b). Sodium valproate and cognitive function. Epilepsia 25 (suppl 1): 60–4CrossRefGoogle Scholar
Trimble, M. R. & Thompson, P. J. (1985). Anticonvulsant drugs and cognitive function. Ann. Neurol. 18: 412Google Scholar
Turner, M. (1977). Appearance, disappearance and migration of EEG foci in child hood. Electroencephalogr. Clin. Neurophysiol. 43: 578Google Scholar
Turrentine, L. K. A., Martin, R. C., Gilliam, F. G., et al. (1999). Differential cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia 40 (suppl 7): 83Google Scholar
Vallarta, J. M., Bell, D. B. & Reichert, A. (1976). Progressive encephalopathy due to chronic hydantoin intoxication. Am. J. Dis. Child 128: 27–34Google Scholar
Vining, E. P. G. (1990). Cognitive and behavioral side effects of antiepileptic drugs. Int. Pediatr. 5: 182Google Scholar
Vining, E. P. G., Botsford, E. & Freeman, J. M. (1979). Valproate sodium in refractory seizures. Am. J. Dis. Child 133: 274–6CrossRefGoogle ScholarPubMed
Vining, E. P. G., Mellits, E. D., Cataldo, M. F., et al. (1983). Effects of phenobarbital and sodium valproate on neuropsychological functions and behavior. Ann. Neurol. 14: 360Google Scholar
Vining, E. P. G., Mellits, E. D., Dorsen, M. M., et al. (1987). Psychologic and behavioral effects of antiepileptic drugs in children: a double blind comparison between phenobarbital and valproic acid. Pediatrics 80: 165–74Google ScholarPubMed
Vinten, J., Gorry, J. & Baker, G. A. (2001). The long-term neuropsychological development of children exposed to antiepileptic drugs in utero. The Liverpool and Manchester Neurodevelopmental Study Group. Epilepsia 42 (suppl 7): 293–4Google Scholar
Wapner, I., Thurston, D. L. & Hollowach, J. (1962). Phenobarbital: its effects on learning in epileptic children. JAMA 182: 937Google Scholar
Waxman, S. G. & Geschwind, N. (1975). The interictal behavior syndrome of temporal lobe epilepsy. Arch. Gen. Psychiatry 32: 1580–86CrossRefGoogle ScholarPubMed
Wilner, A. (2002). Antiepileptic reduces seizures in children and adults. CNS News 4: 16Google Scholar
Wilson, A., Petty, R., Perry, A., et al. (1983). Paroxysmal language disturbance in an epileptic treated with clobazam. Neurology 33: 652–4CrossRefGoogle Scholar
Wolf, S. M. (1979). Controversies in the treatment of febrile convulsions. Neurology 29: 287–90CrossRefGoogle ScholarPubMed
Zavyazkina, N. (1998). Carbamazepine effect on cognitive functions of patients with epilepsy. 3rd European Congress of Epileptology. Epilepsia 39 (suppl 2): 120Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×